Enanta Pharmaceuticals, Inc. (ENTA)
15.90
-0.53
(-3.23%)
USD |
NASDAQ |
Dec 30, 16:00
15.90
0.00 (0.00%)
After-Hours: 20:00
Enanta Pharmaceuticals Market Cap: 458.92M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agios Pharmaceuticals, Inc. | 1.594B |
| NovaBay Pharmaceuticals, Inc. | 781.27M |
| Palatin Technologies, Inc. | 13.47M |
| Theriva Biologics, Inc. | 6.613M |
| Oragenics, Inc. | 0.6208M |
Market Cap Related Metrics
| PS Ratio | 5.194 |
| Price to Book Value | 7.091 |
| Price | 15.90 |
| Earnings Yield | -24.14% |